SEOM-GEIS clinical guideline for gastrointestinal stromal tumors (2022)

por Serrano, César, Álvarez, Rosa, Carrasco, Juan Antonio, Marquina, Gloria, Martínez-García, Jerónimo, Martínez-Marín, Virginia, Sala, María Ángeles, Sebio, Ana, Sevilla, Isabel, Martín-Broto, Javier
Publicado 2023

Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas

por Escoll, Maribel, Lastra, Diego, Pajares, Marta, Robledinos-Antón, Natalia, Rojo, Ana I., Fernández-Ginés, Raquel, Mendiola, Marta, Martínez-Marín, Virginia, Esteban, Isabel, López-Larrubia, Pilar, Gargini, Ricardo, Cuadrado, Antonio
Publicado 2020

Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer

por Muñoz Martín, Andrés J., Ortega, Israel, Font, Carme, Pachón, Vanesa, Castellón, Victoria, Martínez-Marín, Virginia, Salgado, Mercedes, Martínez, Eva, Calzas, Julia, Rupérez, Ana, Souto, Juan C., Martín, Miguel, Salas, Eduardo, Soria, Jose M.
Publicado 2018

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts

por Muñoz, Andrés, Ay, Cihan, Grilz, Ella, López, Sonia, Font, Carme, Pachón, Vanesa, Castellón, Victoria, Martínez-Marín, Virginia, Salgado, Mercedes, Martínez, Eva, Calzas, Julia, Ortega, Laura, Rupérez, Ana, Salas, Eduardo, Pabinger, Ingrid, Soria, Jose Manuel
Publicado 2023

Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?

por Escudero, Javier, Heredia-Soto, Victoria, Wang, Yinyin, Ruiz, Patricia, Hu, Yingying, Gallego, Alejandro, Pozo-Kreilinger, Jose Juan, Martinez-Marin, Virginia, Berjon, Alberto, Ortiz-Cruz, Eduardo, Bernabeu, Daniel, Feliu, Jaime, Tang, Jing, Redondo, Andres, Mendiola, Marta
Publicado 2021

2023 GEIS Guidelines for gastrointestinal stromal tumors

por Serrano, César, Martín-Broto, Javier, Asencio-Pascual, José Manuel, López-Guerrero, José Antonio, Rubió-Casadevall, Jordi, Bagué, Silvia, García-del-Muro, Xavier, Fernández-Hernández, Juan Ángel, Herrero, Luís, López-Pousa, Antonio, Poveda, Andrés, Martínez-Marín, Virginia
Publicado 2023

Predictive value of angiogenesis-related gene profiling in patients with HER2-negative metastatic breast cancer treated with bevacizumab and weekly paclitaxel

por Mendiola, Marta, Martínez-Marin, Virginia, Herranz, Jesús, Heredia, Victoria, Yébenes, Laura, Zamora, Pilar, Castelo, Beatriz, Pinto, Álvaro, Miguel, María, Díaz, Esther, Gámez, Angelo, Fresno, Juan Ángel, de Molina, Ana Ramírez, Hardisson, David, Espinosa, Enrique, Redondo, Andrés
Publicado 2016

Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients

por Rosas-Alonso, Rocio, Colmenarejo-Fernandez, Julian, Pernia, Olga, Rodriguez-Antolín, Carlos, Esteban, Isabel, Ghanem, Ismael, Sanchez-Cabrero, Dario, Losantos-Garcia, Itsaso, Palacios-Zambrano, Sara, Moreno-Bueno, Gema, de Castro, Javier, Martinez-Marin, Virginia, Ibanez-de-Caceres, Inmaculada
Publicado 2021

A phase II trial of weekly nab-paclitaxel for progressive and symptomatic desmoid tumors

por Martin-Broto, Javier, Redondo, Andres, Moura, David S., Valverde, Claudia, Morales, Jose Manuel, Lopez-Pousa, Antonio, Martinez-Trufero, Javier, Gutierrez, Antonio, Díaz-Beveridge, Roberto, Luna, Pablo, Martinez-Marin, Virginia, Marcilla, David, Arribas, Ivan, Ledesma, Patricio, Lopez-Martin, Jose Antonio, Di Lernia, Davide, Zamora, Jorge, Hindi, Nadia
Publicado 2022

MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer

por Burdiel, Miranda, Jiménez, Julia, Rodríguez-Antolín, Carlos, García-Guede, Álvaro, Pernía, Olga, Sastre-Perona, Ana, Rosas-Alonso, Rocío, Colmenarejo, Julián, Rodríguez-Jiménez, Carmen, Diestro, María Dolores, Martínez-Marín, Virginia, Higueras, Oliver, Cruz, Patricia, Losantos-García, Itsaso, Peinado, Héctor, Vera, Olga, de Castro, Javier, Ibáñez de Cáceres, Inmaculada
Publicado 2023

REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial

por Martin-Broto, Javier, Valverde, Claudia, Hindi, Nadia, Vincenzi, Bruno, Martinez-Trufero, Javier, Grignani, Giovanni, Italiano, Antoine, Lavernia, Javier, Vallejo, Ana, Tos, Paolo Dei, Le Loarer, Francois, Gonzalez-Campora, Ricardo, Ramos, Rafael, Hernández-Jover, Diana, Gutierrez, Antonio, Serrano, Cesar, Monteagudo, Maria, Letón, Rocio, Robledo, Mercedes, Moura, David S., Martin-Ruiz, Marta, López-Guerrero, Jose A., Cruz, Julia, Fernandez-Serra, Antonio, Blay, Jean-Yves, Fumagalli, Elena, Martinez-Marin, Virginia
Publicado 2023